Literature DB >> 690425

A study of acute respiratory disease in the community of Port Chalmers. II. Influenza A/Port Chalmers/1/73: intrafamilial spread and the effect of antibodies to the surface antigens.

L C Jennings, J A Miles.   

Abstract

During the first year of a study of respiratory disease in the semi-isolated community of Port Chalmers, New Zealand, an epidemic of clinical influenza occurred from which the variant influenza A/Port Chalmers/1/73 (H3N2) was isolated. Within a selected group of 26 families, 59 (46%) members had clinical or laboratory evidence of infection. During intrafamilial spread the infection frequency was highest for school-aged children (77%), followed by female adults (67%), infants (64%) and male adults (41%). The index infection in each family was a school-age child on 10 occasions, suggesting the role of this age group in the transmission of influenza A in this community. The secondary attack rate (SAR) of 58.3% was higher than expected. In sera taken before the 1973 epidemic, 59% of family members had detectable HI antibody and 25% NI antibody to A/England/42/72 while 38% had detectable HI antibody and 8% NI antibody to A/Port Chalmers/1/73. The relation between pre-existing antibody and infection frequency is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690425      PMCID: PMC2129753          DOI: 10.1017/s0022172400053778

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  12 in total

1.  Epidemiologic studies on influenza in familial and general population groups, 1951-1956. II. Characteristics of occurrence.

Authors:  R N PHILIP; J A BELL; D J DAVIS; M O BEEM; P M BEIGELMAN; J I ENGLER; G W MELLIN; J H JOHNSON; A M LERNER
Journal:  Am J Hyg       Date:  1961-03

2.  Longitudinal studies of types A and B influenza among Seattle schoolchildren and families, 1968-74.

Authors:  H M Foy; M K Cooney; I Allan
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

3.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  The Seattle virus watch. 3. Evaluation of isolation methods and summary of infections detected by virus isolations.

Authors:  M K Cooney; C E Hall; J P Fox
Journal:  Am J Epidemiol       Date:  1972-10       Impact factor: 4.897

5.  The Seattle virus watch. IV. Comparative epidemiologic observations of infections with influenza A and B viruses, 1965-1969, in families with young children.

Authors:  C E Hall; M K Cooney; J P Fox
Journal:  Am J Epidemiol       Date:  1973-11       Impact factor: 4.897

Review 6.  Effects of immunity on transmission of influenza: experimental studies.

Authors:  J L Schulman
Journal:  Prog Med Virol       Date:  1970

7.  Association of serum anti-neuraminidase antibody with resistance to influenza in man.

Authors:  B R Murphy; J A Kasel; R M Chanock
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

Review 8.  Antigenic variation in influenza virus. Biology and chemistry.

Authors:  R G Webster; W G Laver
Journal:  Prog Med Virol       Date:  1971

9.  A study of acute respiratory disease in the community of Port Chalmers. I. Illnesses within a group of selected families and the relative incidence of respiratory pathogens in the whole community.

Authors:  L C Jennings; R D MacDiarmid; J A Miles
Journal:  J Hyg (Lond)       Date:  1978-08

10.  First outbreak of Hong Kong influenza in a general practice population in Great Britain. A field and laboratory study.

Authors:  R E Hope-Simpson
Journal:  Br Med J       Date:  1970-07-11
View more
  8 in total

1.  Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Daisuke Tamura; Maki Kiso; Eiryo Kawakami; Shuji Hatakeyama; Yasuhiro Ebihara; Tomohiko Koibuchi; Takeshi Fujii; Kazuo Takahashi; Masayuki Shimojima; Yuko Sakai-Tagawa; Mutsumi Ito; Saori Sakabe; Ayaka Iwasa; Kei Takahashi; Takashi Ishii; Takeo Gorai; Koichiro Tsuji; Aikichi Iwamoto; Yoshihiro Kawaoka
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

2.  Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Authors:  Pedro A Piedra; Manjusha J Gaglani; Mark Riggs; Gayla Herschler; Charles Fewlass; Matt Watts; Claudia Kozinetz; Colin Hessel; W Paul Glezen
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

3.  Transmissibility of seasonal and pandemic influenza in a cohort of households in Hong Kong in 2009.

Authors:  Brendan Klick; Hiroshi Nishiura; Sophia Ng; Vicky J Fang; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

4.  Infection with influenza A/Victoria virus in Houston families, 1976.

Authors:  L H Taber; A Paredes; W P Glezen; R B Couch
Journal:  J Hyg (Lond)       Date:  1981-06

5.  Influenza transmission in a community during a seasonal influenza A(H3N2) outbreak (2010-2011) in Mongolia: a community-based prospective cohort study.

Authors:  Nao Nukiwa-Souma; Alexanderyn Burmaa; Taro Kamigaki; Ishiin Od; Namuutsetsegiin Bayasgalan; Badarchiin Darmaa; Akira Suzuki; Pagbajabyn Nymadawa; Hitoshi Oshitani
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

6.  A comparative analysis of influenza vaccination programs.

Authors:  Shweta Bansal; Babak Pourbohloul; Lauren Ancel Meyers
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

7.  Influenza excess mortality from 1950-2000 in tropical Singapore.

Authors:  Vernon J Lee; Jonathan Yap; Jimmy B S Ong; Kwai-Peng Chan; Raymond T P Lin; Siew Pang Chan; Kee Tai Goh; Yee-Sin Leo; Mark I-Cheng Chen
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

8.  Household transmission of influenza A and B within a prospective cohort during the 2013-2014 and 2014-2015 seasons.

Authors:  F Scott Dahlgren; Ivo M Foppa; Melissa S Stockwell; Celibell Y Vargas; Philip LaRussa; Carrie Reed
Journal:  Stat Med       Date:  2021-09-27       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.